Pharmaceuticals - Indian - Formulations
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 133.74 | 115.76 | 92.67 | - | - |
Total Expenses | 119 | 109.10 | 88.26 | - | - |
Profit Before Tax | 13.44 | 6.66 | 4.41 | - | - |
Profit After Tax | 9.65 | 4.88 | 3.13 | - | - |
Operating Profit after Depreciation | 17.73 | 8.98 | 6.52 | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 11.34 | 11.71 | 10.47 | - | - |
Total Non Current Assets | 21.71 | 14 | 15.05 | - | - |
Total Current Assets | 113.33 | 83.92 | 53.53 | - | - |
TOTAL ASSETS | 135.04 | 97.92 | 68.58 | - | - |
Total Shareholder's Fund | 62.26 | 17.72 | 12.09 | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | -13.01 | -4.77 | 5.15 | - | - |
Net Cash used in Investing Activities | 26 | -0.27 | -5.24 | - | - |
Net Cash used in Financing Activities | -4.47 | 4.99 | 1.24 | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 133.74 | 115.76 | 92.60 | 73.52 | 78.33 |
Total Expenses | 119 | 109.10 | 88.20 | 68.92 | 73.46 |
Profit Before Tax | 13.29 | 6.66 | 4.40 | 4.60 | 4.88 |
Profit After Tax | 9.54 | 4.88 | 3.21 | 3.07 | 3.40 |
Operating Profit after Depreciation | 17.74 | 8.98 | 6.54 | 6.09 | 6.19 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 10.94 | 10.82 | 10.45 | 9.21 | 6.40 |
Total Non Current Assets | 21.34 | 13.14 | 12.40 | 10.69 | 9.01 |
Total Current Assets | 112.84 | 84.08 | 53.79 | 35.85 | 34.72 |
TOTAL ASSETS | 134.17 | 97.22 | 66.18 | 46.54 | 43.72 |
Total Shareholder's Fund | 62.22 | 17.73 | 12.85 | 9.64 | 6.57 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | -12.49 | -4.27 | 4.91 | -0.89 | 3.48 |
Net Cash used in Investing Activities | 25.52 | -2.05 | -3.04 | -2.22 | -4.93 |
Net Cash used in Financing Activities | -4.48 | 6.30 | -0.83 | 2.88 | 1.36 |
No data available
No data available
₹0.5/Share
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Zenith Drugs Ltd | ₹77.70 | ₹133.25 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
11 Nov 2024, 03:10 pm
02 Sep 2024, 10:55 am
30 May 2024, 03:14 pm
24 May 2024, 08:04 pm
15 Apr 2024, 10:01 am